Join us for our bi-monthly Medical Student Q&A where you will have the opportunity to meet faculty and resident radiation oncologists.
Tip: Hover on a state to see its rate (and 95% C.I.). Click a state to show its counties.
In the real-world setting, patients with MF and anemia who were treated with ruxolitinib had poorer survival outcomes than patients without anemia.
ASTRO’s member newsletter for week of January 6: Register for Annual Refresher, 2025 ASTRO Coding Resource, Comments needed: WHO Grade 4 Glioma guide
Recently added guidance documents regarding oncology and malignant hematology
Seasonal Affective Disorder (SAD) affects millions of Americans, but hopping into a tanning bed won’t help. Visible light therapy is safer.
There remains a need to synthesize linkages between social determinants of health (SDOH) and cancer screening to reduce persistent inequities contributing to the US cancer…
Online resource for healthcare professionals, providing information, news & support relating to multiple myeloma
A quarterly newsletter for patients living with cancer, survivors, advocates and consumers
The OncoAlert Newsletter is now out for June 23-29, 2023
The Clinical Research Physician provides medical expertise and support for the development, implementation, conduct and reporting of EORTC clinical trials.
